SLNObenzinga

Guggenheim Maintains Buy on Soleno Therapeutics, Raises Price Target to $97

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 8, 2025 by benzinga